Discover 224 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Meridian is home to a wide range of active clinical trials focusing on conditions such as diabetes, chronic pain management, and mental health research. Participants in these trials gain access to the latest healthcare innovations while helping shape the future of medical treatments. The city's leading research institutions offer numerous opportunities for both healthy volunteers interested in paid trials and individuals looking for studies targeting specific conditions.
Filter
2
Filter results
Results: 224
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Boise ID, Tacoma WA, Bellevue WA, Santa Rosa CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 55+
Code: NCT07602582
Phase 3, Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
for
Migraine
Location: Boise ID, Hawthorne CA, Grand Island NE, Sioux Falls SD,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT05156398
Phase 3, Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Nampa ID, Anaconda MT, Bend OR, Missoula MT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05058651
Phase 2, Phase 3, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Nampa ID, Oregon City OR, Clackamas OR, Portland OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors